Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Antigen processing and presentation	9/77	3.0826518930550205E-12	9.494567830609464E-10	0	0	35.964035964035965	953.2350767888253	CD74;HLA-DMA;HSP90AB1;CTSL;PSME2;B2M;CTSS;HLA-DRB1;HLA-DPA1
Influenza A	10/171	1.9120568644261706E-10	2.9445675712163028E-8	0	0	17.99370220422852	402.6571547448462	CXCL10;HLA-DMA;OAS1;STAT1;MX1;CASP1;TNFSF10;CCL2;HLA-DRB1;HLA-DPA1
NOD-like receptor signaling pathway	9/178	5.957621686793269E-9	6.116491598441089E-7	0	0	15.557476231633535	294.63673350413603	HSP90AB1;OAS1;IFI16;STAT1;CASP1;CCL2;CARD16;GBP1;GBP4
Epstein-Barr virus infection	9/201	1.7184147234217627E-8	1.3231793370347574E-6	0	0	13.777267508610793	246.3276034519964	CXCL10;HLA-DMA;OAS1;GADD45B;STAT1;ISG15;B2M;HLA-DRB1;HLA-DPA1
Rheumatoid arthritis	6/91	4.998047298436223E-7	3.0787971358367136E-5	0	0	20.28740490278952	294.3509387344251	HLA-DMA;CTSL;CCL2;HLA-DRB1;TNFSF13B;HLA-DPA1
Staphylococcus aureus infection	5/68	2.7592221507308288E-6	1.4164007040418254E-4	0	0	22.624434389140273	289.60546939823416	CFD;HLA-DMA;C3AR1;HLA-DRB1;HLA-DPA1
Intestinal immune network for IgA production	4/48	1.7753258438002102E-5	7.811433712720925E-4	0	0	25.641025641025642	280.48567910047535	HLA-DMA;HLA-DRB1;TNFSF13B;HLA-DPA1
Tuberculosis	6/179	2.5196816509408514E-5	9.700774356122278E-4	0	0	10.313708637730985	109.20972480019391	CD74;HLA-DMA;STAT1;CTSS;HLA-DRB1;HLA-DPA1
Th17 cell differentiation	5/107	2.5528523405702857E-5	8.736428009951644E-4	0	0	14.378145219266715	152.05915407617542	HLA-DMA;HSP90AB1;STAT1;HLA-DRB1;HLA-DPA1
Herpes simplex virus 1 infection	9/492	2.8848099225686562E-5	8.885214561511461E-4	0	0	5.628517823639775	58.83752224337089	BST2;CD74;HLA-DMA;OAS1;STAT1;CCL2;B2M;HLA-DRB1;HLA-DPA1
Inflammatory bowel disease (IBD)	4/65	5.926761769185078E-5	0.001659493295371822	0	0	18.93491124260355	184.30196406413557	HLA-DMA;STAT1;HLA-DRB1;HLA-DPA1
Leishmaniasis	4/74	9.854339481142582E-5	0.002529280466826596	0	0	16.632016632016633	153.43057879985963	HLA-DMA;STAT1;HLA-DRB1;HLA-DPA1
Apoptosis	5/143	1.0192283199661782E-4	0.002414787096535253	0	0	10.758472296933837	98.88428811253823	GADD45B;CTSL;TNFSF10;CTSS;MCL1
Phagosome	5/152	1.3580151067745148E-4	0.0029876332349039326	0	0	10.121457489878543	90.12465808319715	HLA-DMA;CTSL;CTSS;HLA-DRB1;HLA-DPA1
Asthma	3/31	1.379928839542096E-4	0.0028334538838597706	0	0	29.77667493796526	264.664271156898	HLA-DMA;HLA-DRB1;HLA-DPA1
Th1 and Th2 cell differentiation	4/92	2.290552443215702E-4	0.0044093134531902264	0	0	13.377926421404682	112.12772363779526	HLA-DMA;STAT1;HLA-DRB1;HLA-DPA1
IL-17 signaling pathway	4/93	2.3876907038645557E-4	0.004325933745825195	0	0	13.234077750206785	110.37238982073303	CXCL10;HSP90AB1;CCL7;CCL2
Allograft rejection	3/38	2.548085324307646E-4	0.004360057110481972	0	0	24.291497975708502	201.012100762348	HLA-DMA;HLA-DRB1;HLA-DPA1
Graft-versus-host disease	3/41	3.1975326308973976E-4	0.005183368685875781	0	0	22.5140712945591	181.1923657582559	HLA-DMA;HLA-DRB1;HLA-DPA1
Type I diabetes mellitus	3/43	3.6846447138337313E-4	0.005674352859303946	0	0	21.466905187835422	169.72092161301057	HLA-DMA;HLA-DRB1;HLA-DPA1
Proteasome	3/45	4.2171165219509206E-4	0.006185104232194684	0	0	20.512820512820515	159.40900033053455	PSME2;PSMB8;PSMB9
Toxoplasmosis	4/113	5.015888163253838E-4	0.007022243428555373	0	0	10.891763104152485	82.75267381779332	HLA-DMA;STAT1;HLA-DRB1;HLA-DPA1
Autoimmune thyroid disease	3/53	6.83420062921915E-4	0.009151886059997817	0	0	17.416545718432513	126.93876681343315	HLA-DMA;HLA-DRB1;HLA-DPA1
Viral myocarditis	3/59	9.353311806859376E-4	0.012003416818802867	0	0	15.64537157757497	109.12036329776505	HLA-DMA;HLA-DRB1;HLA-DPA1
Hepatitis C	4/155	0.0016275432915230108	0.02005133335156349	0	0	7.94044665012407	50.98309545783572	CXCL10;OAS1;STAT1;MX1
Necroptosis	4/162	0.0019127170484483568	0.022658340420080532	0	0	7.597340930674264	47.553508142968695	HSP90AB1;STAT1;CASP1;TNFSF10
Cytokine-cytokine receptor interaction	5/294	0.0026680596437117354	0.03043564334308202	0	0	5.232862375719519	31.012055447223137	CXCL10;CCL7;TNFSF10;CCL2;TNFSF13B
Chemokine signaling pathway	4/190	0.003401226801428545	0.037413494815713995	0	0	6.477732793522267	36.81696575541218	CXCL10;CCL7;STAT1;CCL2
Hematopoietic cell lineage	3/97	0.0038859998059354536	0.04127199793890068	0	0	9.516256938937351	52.818794397776045	HLA-DMA;HLA-DRB1;HLA-DPA1
Human T-cell leukemia virus 1 infection	4/219	0.005621842840686268	0.05771758649771235	0	0	5.619950825430277	29.11750339996382	HLA-DMA;B2M;HLA-DRB1;HLA-DPA1
Lysosome	3/123	0.00751346013072673	0.07464986194399462	0	0	7.5046904315197	36.705885049637835	CTSL;NPC2;CTSS
Systemic lupus erythematosus	3/133	0.009301013870010541	0.08952225849885147	0	0	6.940427993059572	32.46476714737502	HLA-DMA;HLA-DRB1;HLA-DPA1
Measles	3/138	0.010280133526324326	0.09594791291236038	0	0	6.688963210702341	30.619010234765337	OAS1;STAT1;MX1
Fluid shear stress and atherosclerosis	3/139	0.010482874703484902	0.09496251201980441	0	0	6.640841173215275	30.269035975225226	HSP90AB1;CTSL;CCL2
Cell adhesion molecules (CAMs)	3/145	0.0117481564702883	0.10338377693853704	0	0	6.366047745358091	28.291091438814643	HLA-DMA;HLA-DRB1;HLA-DPA1
Cytosolic DNA-sensing pathway	2/63	0.017882929022996263	0.15299839275230137	0	0	9.768009768009767	39.30557955603675	CXCL10;CASP1
RIG-I-like receptor signaling pathway	2/70	0.021794992887509062	0.18142858944196733	0	0	8.791208791208792	33.63582434837569	CXCL10;ISG15
Human papillomavirus infection	4/330	0.022420938841438028	0.18172760955691877	0	0	3.72960372960373	14.164139811801272	STAT1;MX1;ISG15;OASL
Pancreatic cancer	2/75	0.024786276879997394	0.19574803279587685	0	0	8.205128205128206	30.338175430397662	GADD45B;STAT1
Complement and coagulation cascades	2/79	0.027292973640561793	0.2101558970323258	0	0	7.789678675754625	28.05161429968184	CFD;C3AR1
Human immunodeficiency virus 1 infection	3/212	0.031731156295273344	0.23837063753522414	0	0	4.354136429608128	15.023757180029804	BST2;B2M;APOBEC3A
Salmonella infection	2/86	0.031913456894228094	0.23403201722433936	0	0	7.155635062611807	24.649212965505477	CASP1;ARPC5
Salivary secretion	2/90	0.034682418206133506	0.248422902499747	0	0	6.837606837606838	22.984768549562357	CST3;LYZ
NF-kappa B signaling pathway	2/95	0.038270020304469736	0.26789014213128814	0	0	6.477732793522267	21.13741505416209	GADD45B;TNFSF13B
AGE-RAGE signaling pathway in diabetic complications	2/100	0.04199313241076799	0.28741966183370093	0	0	6.153846153846154	19.50922577291064	STAT1;CCL2
Toll-like receptor signaling pathway	2/104	0.045065714532955874	0.3017443494815306	0	0	5.91715976331361	18.341026813561403	CXCL10;STAT1
C-type lectin receptor signaling pathway	2/104	0.045065714532955874	0.2953242569393704	0	0	5.91715976331361	18.341026813561403	STAT1;CASP1
TNF signaling pathway	2/110	0.04982535596185024	0.3197127007552057	0	0	5.594405594405594	16.778916188346557	CXCL10;CCL2
Glycosaminoglycan degradation	1/19	0.0600026111891116	0.3771592703315586	0	0	16.194331983805668	45.56060239495497	HPSE
Natural killer cell mediated cytotoxicity	2/131	0.06779583253668175	0.41762232842595964	0	0	4.697592483852026	12.642417160002609	TNFSF10;CD48
FoxO signaling pathway	2/132	0.06869866077295063	0.41488602976605476	0	0	4.662004662004662	12.484967709964357	GADD45B;TNFSF10
JAK-STAT signaling pathway	2/162	0.09749658406469142	0.577479767152403	0	0	3.798670465337132	8.843069085758852	STAT1;MCL1
Protein processing in endoplasmic reticulum	2/165	0.10054073677116228	0.5842744702927921	0	0	3.72960372960373	8.56761694211614	DNAJA1;HSP90AB1
African trypanosomiasis	1/37	0.11357092133098767	0.6477748846285963	0	0	8.316008316008316	18.090043905705823	IDO1
Thyroid cancer	1/37	0.11357092133098767	0.635997159453531	0	0	8.316008316008316	18.090043905705823	GADD45B
Glycine, serine and threonine metabolism	1/40	0.12220187846195762	0.6721103315407669	0	0	7.692307692307693	16.169852771797522	SDS
Tryptophan metabolism	1/42	0.12790982545773796	0.6911618638768999	0	0	7.326007326007326	15.065419428151298	IDO1
Proteoglycans in cancer	2/201	0.13892827326220888	0.737757037323454	0	0	3.0616150019135095	6.043008032856538	CTSL;HPSE
Cysteine and methionine metabolism	1/47	0.14202029523984686	0.7413940836249633	0	0	6.546644844517185	12.777645220093595	SDS
Arginine and proline metabolism	1/49	0.1476013260006852	0.7576868068035174	0	0	6.279434850863422	12.01406833979051	LAP3
Malaria	1/49	0.1476013260006852	0.7452657116100171	0	0	6.279434850863422	12.01406833979051	CCL2
Cholesterol metabolism	1/50	0.15037842149138922	0.7470411906346432	0	0	6.153846153846154	11.659079088530438	NPC2
Amyotrophic lateral sclerosis (ALS)	1/51	0.1531466080202981	0.7487167503214573	0	0	6.033182503770739	11.320419873525108	CASP1
Mineral absorption	1/51	0.1531466080202981	0.7370180510976846	0	0	6.033182503770739	11.320419873525108	MT2A
Regulation of actin cytoskeleton	2/214	0.15348818915049378	0.7272978808977244	0	0	2.8756290438533427	5.389307429360722	TMSB4X;ARPC5
Legionellosis	1/55	0.1641308259668801	0.7659438545121072	0	0	5.594405594405594	10.109602516680464	CASP1
Pathogenic Escherichia coli infection	1/55	0.1641308259668801	0.7545118566835682	0	0	5.594405594405594	10.109602516680464	ARPC5
Human cytomegalovirus infection	2/225	0.16603356814293932	0.7520343968827251	0	0	2.735042735042735	4.9109478108452445	CCL2;B2M
Glutathione metabolism	1/56	0.16685488800257076	0.7448015290549536	0	0	5.4945054945054945	9.838630650680285	LAP3
Endometrial cancer	1/58	0.17227681533370462	0.7580179874683003	0	0	5.305039787798409	9.329722569635413	GADD45B
VEGF signaling pathway	1/59	0.1749747357749802	0.7590453326576606	0	0	5.215123859191656	9.09055375478829	HSPB1
Basal cell carcinoma	1/63	0.185680101911481	0.7942982137324465	0	0	4.8840048840048835	8.223345387842004	GADD45B
Shigellosis	1/65	0.19098137657793157	0.8057844381644236	0	0	4.733727810650888	7.837062061618913	ARPC5
Aminoacyl-tRNA biosynthesis	1/66	0.19361925643389596	0.8058747429951345	0	0	4.662004662004662	7.65436663885718	WARS
Non-small cell lung cancer	1/66	0.19361925643389596	0.7951297464218661	0	0	4.662004662004662	7.65436663885718	GADD45B
Prolactin signaling pathway	1/70	0.2040863516150643	0.8270867933873658	0	0	4.395604395604396	6.9855476152531715	STAT1
p53 signaling pathway	1/72	0.20926961733498772	0.8370784693399508	0	0	4.273504273504273	6.6843240312052785	GADD45B
Melanoma	1/72	0.20926961733498772	0.8263466940920028	0	0	4.273504273504273	6.6843240312052785	GADD45B
Bacterial invasion of epithelial cells	1/74	0.2144196438115004	0.835965193594204	0	0	4.158004158004158	6.40257892610154	ARPC5
Glioma	1/75	0.21698225796024237	0.8353816931469332	0	0	4.102564102564103	6.268470520353364	GADD45B
Chronic myeloid leukemia	1/76	0.21953664088892447	0.8347813011578856	0	0	4.048582995951417	6.138607819915219	GADD45B
Pertussis	1/76	0.21953664088892447	0.8246010413876674	0	0	4.048582995951417	6.138607819915219	CASP1
Colorectal cancer	1/86	0.24463343883496388	0.9077963754357695	0	0	3.5778175313059033	5.037546893864017	GADD45B
Pathways in cancer	3/530	0.24758143171914787	0.9077985829702089	0	0	1.741654571843251	2.4313771855568693	HSP90AB1;GADD45B;STAT1
MAPK signaling pathway	2/295	0.24891560973720164	0.9019530329300954	0	0	2.0860495436766624	2.9009467675217646	GADD45B;HSPB1
Fc gamma R-mediated phagocytosis	1/91	0.2568821449606544	0.9199965191614135	0	0	3.38123415046492	4.5955634122957845	ARPC5
Small cell lung cancer	1/93	0.26172668236340957	0.9265726226198868	0	0	3.308519437551696	4.434919824039912	GADD45B
Amoebiasis	1/96	0.26893523781429146	0.9412733323500201	0	0	3.2051282051282053	4.209245769183832	HSPB1
Prostate cancer	1/97	0.2713226543232256	0.9389592981073426	0	0	3.1720856463124507	4.137816209209656	HSP90AB1
Progesterone-mediated oocyte maturation	1/99	0.27607448076764396	0.9447882230714926	0	0	3.1080031080031083	4.000262911627929	HSP90AB1
Chagas disease (American trypanosomiasis)	1/103	0.28548678503831637	0.9662629647450708	0	0	2.9873039581777445	3.744763369794043	CCL2
Parathyroid hormone synthesis, secretion and action	1/106	0.29246683985974964	0.9791281160522053	0	0	2.9027576197387517	3.568661790240114	MAFB
Thyroid hormone signaling pathway	1/116	0.31525228516270304	1.0	0	0	2.6525198938992043	3.062021367192494	STAT1
PI3K-Akt signaling pathway	2/354	0.319974507062947	1.0	0	0	1.738374619730552	1.9809021326207985	HSP90AB1;MCL1
Cell cycle	1/124	0.33295909137080504	1.0	0	0	2.4813895781637716	2.7288725689442646	GADD45B
Osteoclast differentiation	1/127	0.3394822527445883	1.0	0	0	2.4227740763173835	2.61740425931999	STAT1
Autophagy	1/128	0.3416426504106414	1.0	0	0	2.4038461538461537	2.5817066587243978	CTSL
Ubiquitin mediated proteolysis	1/137	0.3607757607501965	1.0	0	0	2.2459292532285233	2.289721897825256	UBE2L6
Estrogen signaling pathway	1/137	0.3607757607501965	1.0	0	0	2.2459292532285233	2.289721897825256	HSP90AB1
Parkinson disease	1/142	0.37116759167574376	1.0	0	0	2.1668472372697725	2.147565739522382	UBE2L6
Breast cancer	1/147	0.38139304025339804	1.0	0	0	2.0931449502878077	2.017634398484288	GADD45B
Gastric cancer	1/149	0.38543722157009613	1.0	0	0	2.065049044914817	1.9687701571592418	GADD45B
Cellular senescence	1/160	0.40721924308759594	1.0	0	0	1.9230769230769234	1.7276991495597303	GADD45B
Hepatitis B	1/163	0.4130266789363932	1.0	0	0	1.8876828692779615	1.669170533645148	STAT1
Hepatocellular carcinoma	1/168	0.4225814943339928	1.0	0	0	1.8315018315018314	1.5776061626142943	GADD45B
Transcriptional misregulation in cancer	1/186	0.4557277406930319	1.0	0	0	1.654259718775848	1.3000160589953416	GADD45B
Kaposi sarcoma-associated herpesvirus infection	1/186	0.4557277406930319	1.0	0	0	1.654259718775848	1.3000160589953416	STAT1
Endocytosis	1/244	0.5502946190985201	1.0	0	0	1.2610340479192939	0.7532174944362476	ARPC5
MicroRNAs in cancer	1/299	0.624939028936179	1.0	0	0	1.0290712631849757	0.4837676230579069	MCL1
Neuroactive ligand-receptor interaction	1/338	0.6703346630422847	1.0	0	0	0.9103322712790168	0.3641130580120422	C3AR1
